Advertisement

Cholesterol-Lowering and High-Density Lipoprotein-Raising Properties of Lecithinated Soy Proteins in Type II Hyperlipidemic Patients

  • G. Noseda
  • C. R. Sirtori
  • G. C. Descovich

Abstract

Numerous dietary factors may favour an increased incidence of atherosclerosis. Among atherogenic factors in the diet, animal fat is the most widely recognized. A direct correlation has been established between saturated fatty acid and cholesterol intake, hypercolesterolemia, and the development of coronary heart disease [1]. In recent years, considerable interest has also been devoted to nutrients from vegetable sources. This interest has been particularly addressed to dietary components such as fibres, vegetable fat, and vegetable proteins. Epidemiological data show, in fact, that vegetable protein intake is negatively correlated with plasma cholesterol and coronary heart disease development [2].

Keywords

Plasma Cholesterol Animal Protein Soybean Protein Hyperlipidemic Patient Atherogenic Factor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Shekelle RB, Shryock AMC, Oglesby P, Lepper M, Stamler J, Lin S, Raynor WJ Jr (1981) Diet, serum cholesterol and death from coronary heart disease. N Engl J Med 304: 65–79PubMedCrossRefGoogle Scholar
  2. 2.
    Carrol KK (1978) Dietary protein in relation to plasma cholesterol levels and atherosclerosis. Nutr Rev 36: 1–5CrossRefGoogle Scholar
  3. 3.
    Sirtori CR, Agradi E, Conti F, Mantero O, Gatti E (1977) Soybean protein in the treatment of type II hyperlipoproteinaemia. Lancet I: 275–277Google Scholar
  4. 4.
    Descovich GC, Gaddi A, Mannino G, Cattin L, Senin U, Caruzzo C, Fragiacomo C, et al (1980) Multicenter study of soybean protein diet for outpatient hypercholesterolaemic patients. Lancet 2: 709–712PubMedCrossRefGoogle Scholar
  5. 5.
    Van Raaij JMA, Katan MB, West CE, Hautoast JGAJ (1982) Influence of diets containing casein, soy isolate and soy concentrate on serum cholesterol and lipoproteins in middle-aged volunteers. Am J Clin Nutr 35: 925–934PubMedGoogle Scholar
  6. 6.
    Descovich GC, Mannino G, Benassi MS, Ceredi C, Cordaro CI, Dormi A, Gaddi A et al (1982) Treatment of hypercholesterolemic patients with soybean protein. In: Lenzi S, Descovich GC (eds) Atherosclerosis: clinical evaluation and therapy. MTP Press, Lancaster, pp 249–265Google Scholar
  7. 7.
    Sirtori CR, Zucchi-Dentone C, Sirtori M, Gatti E, Descovich GC, Gaddi A, Cattin L et al (1985) Cholesterol-lowering and HDL-raising properties of lecithinated soy proteins in the type II hyperlipidemic patients. Ann Nutr Metab 29: 348–357PubMedCrossRefGoogle Scholar
  8. 8.
    Blaton V, Soeteway F, Vandanne D, Declercq B, Peeters H (1976) Effects of polyunsaturated phosphatidylcholine on human types II and IV hyperlipoproteinemias. Artery 2: 309–325Google Scholar
  9. 9.
    Greten H, Raetzer H, Stiehl A, Schettler G (1980) The effect of polyunsaturated phosphatidylcholine in man. Atherosclerosis 36: 81–88PubMedCrossRefGoogle Scholar
  10. 10.
    Zierenberg O, Grundy SM (1982) Intestinal absorption of polyenephosphatidylcholine in man. J Lipid Res 23: 1136–1142PubMedGoogle Scholar
  11. 11.
    Zierenberg O, AssmannG, Schmitz G, Rosseneu M (1981) Effect of polyenephosphatidylcholine and cholesterol uptake by human high density lipoprotein. Atherosclerosis 39: 527–542Google Scholar
  12. 12.
    Ter Welle HF, van Gent CM, Dekker W, Willebrands AF (1974) The effect of soya lecithin on serum lipid values in type II hyperlipoproteinemia. Acta Med Scand 195: 267–271PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1987

Authors and Affiliations

  • G. Noseda
  • C. R. Sirtori
  • G. C. Descovich

There are no affiliations available

Personalised recommendations